Advertisement
NeuroScientistNews
NeuroScientistNews

The Nutshell

Daily News Roundup

Most Recent

Gene therapy trial set to resume

By | November 26, 2007

The US Food and Drug Administration is allowing a controversial gene therapy trial to linkurl:resume,;http://ir.targen.com/phoenix.zhtml?c=84981&p=irol-newsArticle&ID=1080820&highlight= after the trial was linkurl:halted;http://www.the-scientist.com/news/display/53453/ when a 36-year-old participant died in July. The therapy, developed by Seattle based company Targeted Genetics, seeks to treat inflammatory arthritis, and is delivered via an adeno-associated viral (AAV) vector through an injecti

0 Comments

UK foot and mouth lab leaks again

By | November 26, 2007

A Surrey, UK, lab thought to be the linkurl:source;http://www.the-scientist.com/news/display/53474/ of a foot and mouth disease (FMD) outbreak in August again ran afoul of biosafety practices last week, when a leaking valve likely released live FMD virus into a contained drainage system. Merial, a company on the site that makes FMD vaccine, had been banned from using live virus after the August outbreak, but the government restored its license to work with FMD earlier this month when biosafety

0 Comments

Academic publishers make open access deal

By | November 21, 2007

The fifth-largest academic journal publisher, SAGE, yesterday (November 20) announced an agreement with linkurl:open access;http://www.the-scientist.com/article/home/53781/ science and medicine publisher, Hindawi, to launch a new series of open access journals, the Chronicle of Higher Education linkurl:reports.;http://chronicle.com/news/article/3472/journal-publisher-goes-for-open-access Publication will be funded by author charges, using a linkurl:gold open access;http://www.the-scientist.com/

1 Comment

Pharma reaches out for ghostwriter

By | November 21, 2007

Earlier this week, The Scientist linkurl:reported;http://www.the-scientist.com/news/home/53869/ on a trial comparing the efficacy of a hypertension drug, nebivolol, in African American and white American patients. It seems that Forest Laboratories, the drug's manufacturer, is making all kinds of comparisons for marketing purposes, and resorting to some questionable practices to do so. The Wall Street Journal Health Blog linkurl:reports;http://blogs.wsj.com/health/2007/11/21/odd-ghostwriting-off

0 Comments

Judge throws out libel suit against scientist

By | November 20, 2007

A Los Angeles Superior Court judge threw out a linkurl:defamation;http://www.the-scientist.com/news/display/53709/ suit today (November 20) filed by a Korean fertility researcher against a scientist who wrote an opinion piece criticizing his work. Judge James Dunn upheld a motion filed by the defendant, Bruce Flamm of the University of California,Irvine. Flamm's motion claimed that the lawsuit sought to stifle Flamm's criticism of Kwang Yul linkurl:Cha's;http://www.the-scientist.com/article/dis

1 Comment

Medical group threatens to sue journal

By | November 20, 2007

A professional medical association has threatened to sue a scientific journal over an linkurl:article;http://www.ijoeh.com/pfds/IJOEH_1304_LaDou02.pdf accusing the group of pandering to industry. The article was published in the most recent issue of the __International Journal of Occupational and Environmental Health__ (__IJOEH__), and it claims that members of the linkurl:American College of Occupational and Environmental Medicine;http://www.acoem.org/ (ACOEM) have "deeply embedded" conflicts

11 Comments

Two teams reprogram skin cells for pluripotency

By | November 20, 2007

Two studies published today report that human somatic cells can be reprogrammed into a pluripotent state that resembles human embryonic stem cells. As reported in linkurl:Cell;http://images.cell.com/images/Edimages/Cell/IEPs/3661.pdf , Shinya Yamanaka's group from Kyoto University linkurl:reprogrammed;http://www.the-scientist.com/blog/display/24307/ adult human skin cells with four transcription factors to make them display human embryonic stem cell pluripotency. linkurl:Last year;http://www.n

0 Comments

Who's Dolly's daddy?

By | November 20, 2007

We at __The Scientist__ take the time to carefully read each and every press release we're sent, especially those from our elected officials in Washington, D.C. (OK, not really.) Today, we got one from Capitol Hill that still has us scratching our heads. An oddly worded press release from US Senator Sam Brownback (R-KS) alleges that cloning pioneer Ian Wilmut is the biological father of Dolly the sheep. The release begins by describing Brownback's pleasure with linkurl:researchers;http://www.t

0 Comments

Job opportunities in Europe

By | November 19, 2007

For those of you who have dreamed of doing science in Europe but don't know how to find the jobs, MIT is hosting a linkurl:European Career Fair;https://www.euro-career.com/ from February 2nd to the 4th, to introduce job-hunting researchers to European employers from academia and industry. The fair is free to candidates and open to the public. No registration is required, but posting a resume online gives employers a chance to find promising candidates ahead of time. Sven Loebrich, the co-cha

1 Comment

Wilmut leaves nuclear transfer behind

By | November 19, 2007

Ian Wilmut, the Scottish scientist who championed linkurl:somatic-cell nuclear transfer;http://www.the-scientist.com/2007/6/1/34/1/ -- most famously with the cloned sheep Dolly -- is choosing a different technique for his future research in stem cells. Wilmut has said he will shift his therapeutic focus from embryonic stem cells to induced pluripotent stem cells. As opposed to nuclear transfer with embryonic stem cells, this technique transfects adult fibroblast cells with transcription factors

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
NeuroScientistNews
NeuroScientistNews

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
The Scientist
The Scientist